AI assistant
MEMPHASYS LIMITED. — AGM Information 2012
May 15, 2012
65314_rns_2012-05-15_23efbfb1-6979-45fb-9978-5e9255c2ae18.pdf
AGM Information
Open in viewerOpens in your device viewer
==> picture [182 x 23] intentionally omitted <==
==> picture [182 x 23] intentionally omitted <==
==> picture [182 x 23] intentionally omitted <==
==> picture [182 x 24] intentionally omitted <==
Wednesday, 16 May 2012
Letter from the Chairman
Dear Shareholders,
I am writing to update you on developments since we announced the signing of the Heads of Agreement ( HOA ) with ABS Novacell Biopharmaceuticals Ltd ( ABS ) on 26[th] April 2012.
We have had a number of meetings with the Board and management of ABS and NuSep is now drafting the contracts to formalise the Joint Venture ( JV ). While there are a number of contracts required to formalise the JV, the ones of particular interest to shareholders will be the:
==> picture [12 x 9] intentionally omitted <==
- Subscription Agreement - defines the $20m Investment by ABS in PrIME Biologics Pte Ltd ( PrIME ); and
==> picture [12 x 9] intentionally omitted <==
==> picture [12 x 9] intentionally omitted <==
- Membrane Supply Agreement – defines the pricing/delivery of the membranes from NuSep to PrIME. These are the membranes that PrIME will exclusively purchase from NuSep for its manufacture of therapeutic plasma products.
==> picture [12 x 9] intentionally omitted <==
It is anticipated that it will take about 1 month to finalise these agreements. This suggests a start date for the JV of 1 July 2012.
In the meantime, the Company has located a Singaporean facility that was previously certified for therapeutic manufacturing. Subject to finalisation of the above agreements and approval by the Singaporean Health Sciences Authority ( HSA ), the JV expects to start manufacture of therapeutic plasma products in approximately 12 months. This is ahead of the budgeted timeline.
Below are some pictures of this facility.
==> picture [184 x 173] intentionally omitted <==
Reverse Osmosis Water Tanks
NuSep Holdings Ltd Postal Address 324 Burns Bay Road P.O. Box 823 Lane Cove NSW 2066 Lane Cove NSW 1595
==> picture [245 x 169] intentionally omitted <==
Water for Injection Plant
Contact Details E [email protected] P +612 8415 7300 W nusep.com F +612 8415 7399 ABN 33 120 047 556
==> picture [182 x 23] intentionally omitted <==
==> picture [182 x 23] intentionally omitted <==
==> picture [182 x 23] intentionally omitted <==
==> picture [182 x 24] intentionally omitted <==
==> picture [210 x 130] intentionally omitted <==
200L Bioreactors
==> picture [247 x 185] intentionally omitted <==
Main Facility Hallway
While the Executive Directors have been focused on completing the PrIME HOA, a number of other developments have been progressed. Of most interest to shareholders would be the two offers the Company has received to fund the SpermSep project. NuSep is negotiating with these organisations and will report once it has finalised one or other of these projects.
In a nutshell, it has been a very busy time for the Company and the Board and I look forward to reporting on these developments at the upcoming General Meeting.
Yours sincerely,
John Manusu Executive Chairman
Contact Details E [email protected] P +612 8415 7300 W nusep.com F +612 8415 7399 ABN 33 120 047 556
NuSep Holdings Ltd Postal Address 324 Burns Bay Road P.O. Box 823 Lane Cove NSW 2066 Lane Cove NSW 1595